Products are for research use only, not for human use

All Guides

GLP-1 Receptor Agonists

Incretin receptor pharmacology, peptide engineering and analytical characterisation

Overview

Glucagon-like peptide-1 (GLP-1) receptor agonists are peptides, and a few small molecules, that bind and activate the GLP-1 receptor, a class B G-protein-coupled receptor that signals mainly through Gs and cyclic AMP. Several members also engage the GIP, glucagon or amylin receptors. This guide covers how the class is built, how receptor activity is measured in vitro, and how the compounds are characterised analytically.

The Receptor and Its Signalling

Native GLP-1(7-36) amide is a 30-residue peptide. Its N-terminus engages the receptor transmembrane core while the helical C-terminal region binds the extracellular domain, the two-domain binding model common to class B GPCRs. Activation raises intracellular cAMP and recruits beta-arrestin, and in vitro work quantifies this with cAMP accumulation assays, reporter-gene assays and receptor-internalisation imaging in transfected cell lines. Native GLP-1 is cleaved within minutes by dipeptidyl peptidase-4 between residues 8 and 9, which is the property the engineered analogues are designed around.

How the Analogues Are Engineered

Three structural strategies recur. Substitution at position 8 (Aib in GLP-1 SM) removes the DPP-4 cleavage site. Fatty-acid acylation through a linker, as in GLP-1 SM and GLP-2 TZ, gives reversible albumin binding. Exendin-4 scaffolds (exenatide, lixisenatide) start from a naturally DPP-4 resistant sequence. Multi-receptor agonists combine pharmacophores in one chain: GLP-2 TZ is a GIP and GLP-1 receptor agonist, survodutide and mazdutide target the GLP-1 and glucagon receptors, and GLP-3 RT engages GLP-1, GIP and glucagon receptors. Cagrilintide is an acylated amylin analogue rather than a GLP-1 agonist, and orforglipron is a non-peptide small molecule acting at the same receptor.

How These Compounds Are Characterised

Identity is established by mass spectrometry: an intact mass, or a precursor and fragment transition (MRM) matched against a reference standard, confirms that the sequence in the vial is the one on the label. Purity is a chromatographic figure, the principal peak area by reversed-phase HPLC, and it bounds peptide-related impurities only; it says nothing about counterion, water or residual solvent content, which is why net peptide content is reported separately. Lyophilised material is stored cold, dry and dark, and a certificate states what was measured on one named lot. Acylated analogues add specific analytical points: the lipidated side chain shifts retention time markedly, aggregation can appear as broadened or late-eluting peaks, and the intact mass must account for the full linker and fatty-acid moiety, so a mass calculated from the amino acid residues alone will not match.

Reading the Literature

Most of the published literature on this class is clinical, and its endpoints are organism outcomes that a research-use supplier does not restate. For laboratory work the useful sources are the receptor pharmacology papers: binding affinity and functional potency at each receptor, bias between cAMP and beta-arrestin pathways, and structural studies of the peptide-receptor complex. When comparing reported potencies, check the cell line, receptor species and expression level, because EC50 values for the same compound differ across assay systems.

Compounds in this class

GLP-1 SM

Class:
GLP-1 receptor agonist
Formula:
C187H291N45O59
Molecular weight:
~4113.6 g/mol

GLP-2 TZ

Class:
GIP and GLP-1 receptor dual agonist
Molecular weight:
~4813.5 g/mol

GLP-3 RT

Class:
GLP-1, GIP and glucagon receptor triple agonist

GLP-1 LR

Class:
GLP-1 receptor agonist
Molecular weight:
~3,751 g/mol

GLP-1 DG

Class:
GLP-1 receptor agonist
Molecular weight:
~59,670 g/mol (fusion protein)

Exenatide

Class:
GLP-1 receptor agonist
Sequence:
H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-...
Molecular weight:
~4186.6 g/mol
CAS:
141758-74-9

Survodutide

Class:
Glucagon and GLP-1 receptor dual agonist

Cagrilintide

Class:
Amylin analogue
Cagrilintide: structure and studies

CAGRILINTIDE + GLP-1 SM

Class:
Amylin receptor agonist

Mazdutide

Class:
GLP-1 and glucagon receptor dual agonist
Molecular weight:
~4233.7 g/mol

Orforglipron

No identity data on file for this compound.

Cotadutide

Class:
GLP-1 and glucagon receptor dual agonist

Browse the research catalogue

Buying and verification

Research Use Only. For in-vitro laboratory research by qualified professionals only. Not for human or animal administration. Not a drug, food, cosmetic or dietary supplement. Not intended to diagnose, treat, cure, mitigate or prevent any disease. Volta does not provide dosing, administration or protocol guidance for any material listed.

Your Cart

Your cart is empty

Browse our catalog to add research compounds.